Startup Chief Financial Officer (CFO) -

Job Description Location:

225 Dyer Street, Providence, RI, 02903

Department:

Executive /

Operations Employment Type:

Full-Time or part-time (TBD)

Reports To:

Co-CEO (Korea HQ) Works Closely with: Managing Director (U.S. Subsidiary)

Start Date:

Q1-Q2, 2026

(target) About Orangebiomed Inc. Orangebiomed Inc. is the U.S. subsidiary of Orange Biomed Co., Ltd. (Seoul, Korea), a medical technology company developing and commercializing the OBM Rapid A1c At-Home OTC monitoring system. We are preparing for FDA clearance and a U.S. e-commerce launch while exploring expansion and strategic funding opportunities. The U.S. subsidiary serves as the base for business development, investor relations, and commercialization strategy, while the Korea HQ focuses on R D, manufacturing, and IPO preparation. Role Overview The Startup CFO of Orangebiomed Inc. will lead all U.S.-based financial and capital strategy functions — including fundraising (venture, strategic, and non-dilutive), grant sourcing, and financial operations alignment with the Korea HQ. This role will play a pivotal part in preparing for a potential corporate flip to the U.S. and establishing early relationships with investors, accelerators, and financial institutions interested in healthcare and diagnostics. Working directly with the Co-CEO (Korea HQ) and closely with the Managing Director (U.S.), the Startup CFO will bridge U.S. financial visibility and global investor confidence as Orangebiomed expands toward FDA clearance and U.S. commercialization. Key Responsibilities Lead all financial planning, forecasting, and U.S. subsidiary accounting operations. Identify and cultivate relationships with U.S. venture capital, corporate investors, and healthcare-focused funds to prepare for future Series A/B fundraising. Drive non-dilutive funding strategy including SBIR, NIH, NSF, and state-level innovation grants. Build and maintain the financial model and investor narrative for U.S. fundraising and flip readiness. Collaborate with Co-CEO and Managing Director to ensure transparency and alignment across borders. Oversee U.S. accounting setup (QuickBooks/Xero) and integration with HQ ERP systems. Manage cash flow, burn rate, payroll, and vendor payments for the U.S. entity. Support pitch deck, investor materials, and data room preparation. Coordinate grant submissions and milestone-based reporting for awarded funds. Build financial governance frameworks for future team scale-up and compliance with

U.S. GAAP.

What you won't own (clear boundaries) Group-level IPO preparation and financial audits (HQ leadership owns). R D budget management and manufacturing costs (HQ Finance & Operations own). Daily bookkeeping tasks once systems and vendors are implemented (delegated to accounting vendor or future hires). Qualifications Minimum Bachelor's degree in Finance, Accounting, Economics, or a related field. 7+ years of progressive experience in financial management, startup finance, or fundraising. Proven experience raising or managing venture capital, strategic investment, or government grants. Strong financial modeling and analytical skills (Excel, Sheets, FP&A tools). Understanding of U.S. startup finance structure, including equity, valuation, and investor reporting. Excellent communication skills for investor and stakeholder engagement. Preferred Experience with life sciences or diagnostics startups. Prior exposure to SBIR/STTR or NIH/NSF grant application and compliance. Experience working across international teams or managing cross-border financials. Familiarity with flip transactions or corporate restructuring for U.S. expansion. MBA, CPA, or CFA credentials preferred. Success Metrics (KPIs) Successful submission of ≥ 2 non-dilutive grant applications within first 90 days. Establish and maintain active investor pipeline (≥ 20 targets in 3 months). Financial reporting system live and aligned with HQ by end of Q2 2026. Achieve investor-ready financial model and deck by Month 3. Maintain audit-ready documentation for U.S. subsidiary at all times 30/60/90-Day Success 30Days Helpdesk + telephony live; ticket types/SLA/views configuration; build visibility into U.S. financial structure; align chart of accounts with HQ. Identify 3-5 potential grant or accelerator programs (NSF, BARDA, RI Commerce). Map initial U.S. VC and strategic partner ecosystem relevant to diagnostics. 60Days Establish investor pipeline and meeting cadence with Co-CEO and Managing Director. Support pitch deck and narrative refinement for investor outreach. Evaluate flip-readiness options (Delaware C-Corp vs. current entity) with legal and HQ. 90Days Deliver U.S.

fundraising readiness package:

investor deck, model, and data room. Coordinate HQ and U.S. reporting alignment for consolidated group forecast. Present funding roadmap (dilutive + non-dilutive) for next 12 months. Working Hours & Coverage Standard coverage: Mon-Fri, 9:00 AM-5:00 PM Eastern. Flexible hours for investor meetings and accelerator deadlines. Occasional travel for investor events and grant program visits. Compensation & Benefits Competitive salary + potential performance-based bonus. Health, dental, vision insurance; PTO per company policy. Performance-based bonuses tied to fundraising milestones. How to Apply Send your resume and a brief note: 1.Your experience with startup fundraising (dilutive and non-dilutive); 2.Example of a financial model or grant application you've led; 3.Your perspective on preparing an early-stage healthcare company for a U.S. flip.

CC:

janice@orangebiomed EEO Statement Orangebiomed Inc. is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.